Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains.

Germ-line mutations of the BRCA1 gene predispose women to early-onset breast and ovarian cancer by compromising the gene's presumptive function as a tumor suppressor. Although the biochemical properties of BRCA1 polypeptides are not understood, their expression pattern and subcellular localization suggest a role in cell-cycle regulation. When resting cells are ...
induced to proliferate, the steady-state levels of BRCA1 increase in late G1 and reach a maximum during S phase. Moreover, in S phase cells, BRCA1 polypeptides are hyperphosphorylated and accumulate into discrete subnuclear foci termed "BRCA1 nuclear dots." BRCA1 associates in vivo with a structurally related protein termed BARD1. Here we show that the steady-state levels of BARD1, unlike those of BRCA1, remain relatively constant during cell cycle progression. However, immunostaining revealed that BARD1 resides within BRCA1 nuclear dots during S phase of the cell cycle, but not during the G1 phase. Nevertheless, BARD1 polypeptides are found exclusively in the nuclear fractions of both G1- and S-phase cells. Therefore, progression to S phase is accompanied by the aggregation of nuclear BARD1 polypeptides into BRCA1 nuclear dots. This cell cycle-dependent colocalization of BARD1 and BRCA1 indicates a role for BARD1 in BRCA1-mediated tumor suppression.
Mesh Terms:
BRCA1 Protein, Breast, Carrier Proteins, Cell Compartmentation, Cell Cycle, Cell Nucleus, Epithelial Cells, Female, Fluorescent Antibody Technique, G1 Phase, Humans, S Phase, Tumor Suppressor Proteins, Ubiquitin-Protein Ligases
Proc. Natl. Acad. Sci. U.S.A.
Date: Oct. 28, 1997
Download Curated Data For This Publication
74169
Switch View:
  • Interactions 1